SEC Form 4 · accession 0001574774-18-000043
BIOTELEMETRY, INC. · BEAT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Rebecca W Rimel
Director
Period of report
May 31, 2018
Accepted (ET)
Jun 1, 2018 · 6:14 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001574774
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 31, 2018 | M | 9,338 | $17.67 | A | 120,375 | D | |
| Common StockF2 | May 31, 2018 | S | 9,338 | $42.28 | D | 111,037 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (Right to Buy)F3 | $17.67 | May 31, 2018 | M | 9,338 | D | — | May 8, 2019 | Common Stock | 9,338 | 0 | D |
Explanation of responses
- F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 30, 2018.
- F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $42.10 to $42.90, inclusive. The reporting person undertakes to provide to BioTelemetry, Inc., any security holder of BioTelemetry, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.
- F3The stock options vested in four equal quarterly installments that began on June 30, 2009.